Table 1.
Location | PNA-positive cell counts |
|||
---|---|---|---|---|
Control Group | IN | IV | MNU | |
ST | 1729 ± 121‡§∮ | 12161 ± 81†§∮ | 733 ± 66†‡∮ | 33 ± 8†‡§ |
IT | 1615 ± 116‡§∮ | 862 ± 70†§∮ | 440 ± 55†‡∮ | 19 ± 6†‡§ |
C | 1638 ± 109‡§∮ | 410 ± 61†§∮ | 206 ± 42†‡∮ | 8 ± 3†‡§ |
IN | 1679 ± 104‡§∮ | 423 ± 58†§∮ | 239 ± 36†‡∮ | 3 ± l†‡§ |
SN | 1692 ± 113‡§∮ | 992 ± 73†§∮ | 466 ± 49†‡∮ | 26 ± 7†‡§ |
Average | 1670 ± 118‡§∮ | 780 ± 67†§∮ | 417 ± 48†‡∮ | 18 ± 8†‡§ |
S-opsin positive cell counts | ||||
ST | 220 ± 38‡§∮ | 106 ± 28†∮ | 81 ± 19†∮ | 0†‡§ |
IT | 569 ± 51‡§∮ | 294 ± 29†§∮ | 160 ± 27†‡∮ | 0†‡§ |
C | 871 ± 72‡§∮ | 401 ± 55†§∮ | 280 ± 39†‡∮ | 0†‡§ |
IN | 956 ± 76‡§∮ | 588 ± 51†§∮ | 366 ± 45†‡∮ | 9 ± 4†‡§ |
SN | 870 ± 62‡§∮ | 429 ± 40†§∮ | 311 ± 41†‡∮ | 6 ± 2†‡§ |
Average | 697 ± 66‡§∮ | 362 ± 42†§∮ | 239 ± 37†‡∮ | 3 ± 2†‡§ |
M-opsin positive cell counts | ||||
ST | 1233 ± 88‡§∮ | 890 ± 72†§∮ | 399 ± 51†‡∮ | 13 ± 5†‡§ |
IT | 1179 ± 82‡§∮ | 529 ± 60†§∮ | 313 ± 48†‡∮ | 8 ± 3†‡§ |
C | 1171 ± 85‡§∮ | 300 ± 53†§∮ | 195 ± 37†‡∮ | 0†‡§ |
IN | 1199 ± 86‡§∮ | 287 ± 51†§∮ | 176 ± 40†‡∮ | 0†‡§ |
SN | 1210 ± 83‡§∮ | 573 ± 62†§∮ | 336 ± 57†‡∮ | 10 ± 6†‡§ |
Average | 1198 ± 84‡§∮ | 516 ± 65†§∮ | 283 ± 48†‡∮ | 6 ± 4†‡§ |
p < .05 for difference compared with control group.
p < .05 for difference compared with IN administered group.
p < .05 for difference compared with IV-administered group.
p < .05 for difference compared with MNU group.
All values are presented as mean ± SD; n = 10 per group.